Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > CELLZOME LIMITED
Company Information for

CELLZOME LIMITED

C/O BDO LLP, 5 TEMPLE SQUARE, LIVERPOOL, L2 5RH,
Company Registration Number
05001893
Private Limited Company
Liquidation

Company Overview

About Cellzome Ltd
CELLZOME LIMITED was founded on 2003-12-22 and has its registered office in Liverpool. The organisation's status is listed as "Liquidation". Cellzome Limited is a Private Limited Company registered in with Companies House and the accounts submission requirement is categorised as AUDIT EXEMPTION SUBSIDIARY
Key Data
Company Name
CELLZOME LIMITED
 
Legal Registered Office
C/O BDO LLP
5 TEMPLE SQUARE
LIVERPOOL
L2 5RH
Other companies in TW8
 
Previous Names
CELLZOME (UK) LIMITED10/07/2008
Filing Information
Company Number 05001893
Company ID Number 05001893
Date formed 2003-12-22
Country 
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Liquidation
Lastest accounts 31/12/2020
Account next due 30/09/2022
Latest return 22/12/2015
Return next due 19/01/2017
Type of accounts AUDIT EXEMPTION SUBSIDIARY
Last Datalog update: 2023-12-05 20:55:06
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for CELLZOME LIMITED
There are multiple accountancy firms based at this address. The accountancy firm could be one of these:   GO4PAY LTD   MITCHELL CHARLESWORTH (SERVICES) LIMITED   RAMON LEE JACOBS LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
Companies with same name CELLZOME LIMITED
The following companies were found which have the same name as CELLZOME LIMITED. These may be the same company in different jurisdictions
  Registered addressLast known statusFormation date
CELLZOME AG Richard Hale (+ 1) Prestwood HP16 0SH closed Company formed on the 2009-10-01
CELLZOME THERAPEUTICS INC Delaware Unknown
Cellzome, Inc. Delaware Unknown

Company Officers of CELLZOME LIMITED

Current Directors
Officer Role Date Appointed
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED
 Company Secretary 2013-05-30
ALAN GEORGE BURNS
 Director 2012-12-03
OLEG DUBIANSKIJ
 Director 2017-01-31
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED
 Director 2012-05-21
GLAXO GROUP LIMITED
 Director 2012-05-21
Previous Officers
Officer Role Date Appointed Date Resigned
RICHARD STEPHEN HALE
 Company Secretary 2007-01-01 2012-05-21
CHARLES COHEN
 Director 2003-12-22 2012-05-21
TIMOTHY PETER WARREN EDWARDS
 Director 2004-09-17 2012-05-21
CHERYL KORIS LAWTON
 Company Secretary 2003-12-22 2007-01-01
DAVID BROWN
 Director 2003-12-22 2004-09-17
SWIFT INCORPORATIONS LIMITED
 Nominated Secretary 2003-12-22 2003-12-22
INSTANT COMPANIES LIMITED
 Nominated Director 2003-12-22 2003-12-22

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
ALAN GEORGE BURNS GLAXO OPERATIONS UK LIMITED Director 2017-05-05 CURRENT 1962-01-01 Active
ALAN GEORGE BURNS GLAXOSMITHKLINE HOLDINGS (IRELAND) LIMITED Director 2014-08-29 CURRENT 2014-08-05 Active - Proposal to Strike off
ALAN GEORGE BURNS GLAXOSMITHKLINE INVESTMENTS (IRELAND) LIMITED Director 2013-11-14 CURRENT 2013-10-31 Active
ALAN GEORGE BURNS GLAXOCHEM PTE LTD Director 2013-03-12 CURRENT 2009-01-01 Active
ALAN GEORGE BURNS ESKAYLAB LIMITED Director 2012-12-03 CURRENT 1908-07-29 Active
ALAN GEORGE BURNS WELLCOME CONSUMER PRODUCTS LIMITED Director 2012-12-03 CURRENT 1993-11-19 Liquidation
ALAN GEORGE BURNS MIXIS GENETICS LIMITED Director 2012-12-03 CURRENT 1996-07-17 Liquidation
ALAN GEORGE BURNS GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) LIMITED Director 2012-12-03 CURRENT 2011-11-16 Active
ALAN GEORGE BURNS ALLEN & HANBURYS LIMITED Director 2012-12-03 CURRENT 1893-12-29 Active
ALAN GEORGE BURNS CLARGES PHARMACEUTICALS LIMITED Director 2012-12-03 CURRENT 1908-12-09 Liquidation
ALAN GEORGE BURNS GLAXOSMITHKLINE INTERNATIONAL LIMITED Director 2012-12-03 CURRENT 1988-09-21 Active
ALAN GEORGE BURNS GLAXOSMITHKLINE EXPORT LIMITED Director 2012-12-03 CURRENT 1989-10-18 Active
ALAN GEORGE BURNS DOMANTIS LIMITED Director 2012-12-03 CURRENT 2000-01-17 Active
ALAN GEORGE BURNS GLAXOSMITHKLINE IHC LIMITED Director 2012-12-03 CURRENT 2010-05-18 Active
ALAN GEORGE BURNS EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED Director 2012-12-03 CURRENT 1904-02-09 Active
ALAN GEORGE BURNS MONTROSE FINE CHEMICAL COMPANY LTD. Director 2012-12-03 CURRENT 1998-10-29 Active
ALAN GEORGE BURNS WELLCOME CONSUMER HEALTHCARE LIMITED Director 2012-12-03 CURRENT 1932-02-29 Active
ALAN GEORGE BURNS GLAXO LABORATORIES LIMITED Director 2012-12-03 CURRENT 1929-05-28 Liquidation
ALAN GEORGE BURNS GLAXO WELLCOME UK LIMITED Director 2012-12-03 CURRENT 1950-03-25 Active
ALAN GEORGE BURNS CHARLES MIDGLEY LIMITED Director 2012-12-03 CURRENT 1920-01-13 Liquidation
ALAN GEORGE BURNS BURROUGHS WELLCOME INTERNATIONAL LIMITED Director 2012-12-03 CURRENT 1955-01-26 Active
ALAN GEORGE BURNS GLAXOSMITHKLINE MERCURY LIMITED Director 2012-12-03 CURRENT 2009-08-28 Active
OLEG DUBIANSKIJ ESKAYLAB LIMITED Director 2017-01-31 CURRENT 1908-07-29 Active
OLEG DUBIANSKIJ WELLCOME CONSUMER PRODUCTS LIMITED Director 2017-01-31 CURRENT 1993-11-19 Liquidation
OLEG DUBIANSKIJ MIXIS GENETICS LIMITED Director 2017-01-31 CURRENT 1996-07-17 Liquidation
OLEG DUBIANSKIJ GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) LIMITED Director 2017-01-31 CURRENT 2011-11-16 Active
OLEG DUBIANSKIJ ALLEN & HANBURYS LIMITED Director 2017-01-31 CURRENT 1893-12-29 Active
OLEG DUBIANSKIJ CLARGES PHARMACEUTICALS LIMITED Director 2017-01-31 CURRENT 1908-12-09 Liquidation
OLEG DUBIANSKIJ GLAXOSMITHKLINE INTERNATIONAL LIMITED Director 2017-01-31 CURRENT 1988-09-21 Active
OLEG DUBIANSKIJ GLAXOSMITHKLINE EXPORT LIMITED Director 2017-01-31 CURRENT 1989-10-18 Active
OLEG DUBIANSKIJ DOMANTIS LIMITED Director 2017-01-31 CURRENT 2000-01-17 Active
OLEG DUBIANSKIJ GLAXOSMITHKLINE IHC LIMITED Director 2017-01-31 CURRENT 2010-05-18 Active
OLEG DUBIANSKIJ GLAXOSMITHKLINE HOLDINGS (IRELAND) LIMITED Director 2017-01-31 CURRENT 2014-08-05 Active - Proposal to Strike off
OLEG DUBIANSKIJ WELLCOME CONSUMER HEALTHCARE LIMITED Director 2017-01-31 CURRENT 1932-02-29 Active
OLEG DUBIANSKIJ GLAXO WELLCOME UK LIMITED Director 2017-01-31 CURRENT 1950-03-25 Active
OLEG DUBIANSKIJ CHARLES MIDGLEY LIMITED Director 2017-01-31 CURRENT 1920-01-13 Liquidation
OLEG DUBIANSKIJ BURROUGHS WELLCOME INTERNATIONAL LIMITED Director 2017-01-31 CURRENT 1955-01-26 Active
OLEG DUBIANSKIJ GLAXOSMITHKLINE MERCURY LIMITED Director 2017-01-31 CURRENT 2009-08-28 Active
GLAXO GROUP LIMITED SETFIRST HOLDINGS LIMITED Director 2018-04-16 CURRENT 2018-04-16 Active - Proposal to Strike off
GLAXO GROUP LIMITED GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) (NO.1) LIMITED Director 2017-11-30 CURRENT 1963-03-13 Active
GLAXO GROUP LIMITED HALEON UK FINANCE (USD) LIMITED Director 2016-08-04 CURRENT 2016-08-04 Active
GLAXO GROUP LIMITED HALEON UK IP (NO. 2) LIMITED Director 2015-02-02 CURRENT 2015-02-02 Active
GLAXO GROUP LIMITED HALEON UK HOLDING SRI LANKA LIMITED Director 2015-01-21 CURRENT 2015-01-21 Active
GLAXO GROUP LIMITED HALEON UK FINANCE LIMITED Director 2014-11-06 CURRENT 2014-11-06 Active
GLAXO GROUP LIMITED HALEON UK SERVICES LIMITED Director 2014-09-26 CURRENT 2014-09-26 Active
GLAXO GROUP LIMITED HALEON UK IP LIMITED Director 2014-09-26 CURRENT 2014-09-26 Active
GLAXO GROUP LIMITED HALEON UK TRADING LIMITED Director 2014-09-26 CURRENT 2014-09-26 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE HOLDINGS (IRELAND) LIMITED Director 2014-08-29 CURRENT 2014-08-05 Active - Proposal to Strike off
GLAXO GROUP LIMITED ACTION POTENTIAL VENTURE CAPITAL LIMITED Director 2013-07-10 CURRENT 2013-07-10 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED Director 2012-11-06 CURRENT 2012-11-06 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE INTELLECTUAL PROPERTY HOLDINGS LIMITED Director 2012-11-06 CURRENT 2012-11-06 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED Director 2012-11-06 CURRENT 2012-11-06 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED Director 2012-11-06 CURRENT 2012-11-06 Active
GLAXO GROUP LIMITED HALEON UK TRADING SERVICES LIMITED Director 2012-06-21 CURRENT 2012-06-21 Active
GLAXO GROUP LIMITED MAXINUTRITION LIMITED Director 2011-04-28 CURRENT 1995-07-26 Liquidation
GLAXO GROUP LIMITED GLAXOSMITHKLINE IHC LIMITED Director 2010-05-18 CURRENT 2010-05-18 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE INVESTMENT HOLDINGS LIMITED Director 2009-11-27 CURRENT 2009-11-27 Liquidation
GLAXO GROUP LIMITED DOMANTIS LIMITED Director 2007-01-05 CURRENT 2000-01-17 Active
GLAXO GROUP LIMITED WELLCOME FOUNDATION INVESTMENT COMPANY LIMITED (THE) Director 2006-08-16 CURRENT 1952-12-22 Active - Proposal to Strike off
GLAXO GROUP LIMITED GLAXO TRUSTEES LIMITED Director 2006-08-16 CURRENT 1957-04-10 Liquidation
GLAXO GROUP LIMITED CLARGES PHARMACEUTICALS TRUSTEES LIMITED Director 2006-08-16 CURRENT 1979-05-09 Active
GLAXO GROUP LIMITED MIXIS GENETICS LIMITED Director 2006-05-04 CURRENT 1996-07-17 Liquidation
GLAXO GROUP LIMITED GLAXOSMITHKLINE HOLDINGS LIMITED Director 2006-01-19 CURRENT 2005-12-07 Active
GLAXO GROUP LIMITED WELLCOME FOUNDATION LIMITED(THE) Director 2002-09-05 CURRENT 1924-01-01 Active
GLAXO GROUP LIMITED GLAXO WELLCOME INVESTMENTS B.V. Director 2002-07-09 CURRENT 2002-04-16 Active
GLAXO GROUP LIMITED GLAXO WELLCOME INTERNATIONAL B.V. Director 2002-07-09 CURRENT 2002-04-16 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE UK LIMITED Director 2001-10-24 CURRENT 2001-10-24 Active
GLAXO GROUP LIMITED GLAXOCHEM (UK) UNLIMITED Director 2001-10-04 CURRENT 2001-10-04 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE HOLDINGS (ONE) LIMITED Director 2001-06-11 CURRENT 2001-06-07 Active
GLAXO GROUP LIMITED STAFFORD-MILLER LIMITED Director 2001-05-29 CURRENT 1936-09-14 Liquidation
GLAXO GROUP LIMITED SMITHKLINE BEECHAM MARKETING AND TECHNICAL SERVICES LIMITED Director 2001-05-13 CURRENT 1951-04-16 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE CARIBBEAN LIMITED Director 2001-03-15 CURRENT 1953-07-28 Active
GLAXO GROUP LIMITED SMITHKLINE BEECHAM (EXPORT) LIMITED Director 2001-03-14 CURRENT 1993-10-08 Active
GLAXO GROUP LIMITED HALEON UK RESEARCH LIMITED Director 2001-03-13 CURRENT 1928-03-21 Active
GLAXO GROUP LIMITED SETFIRST LIMITED Director 2001-03-02 CURRENT 1989-01-03 Active
GLAXO GROUP LIMITED DEALCYBER LIMITED Director 2001-03-02 CURRENT 1998-04-07 Active
GLAXO GROUP LIMITED SMITHKLINE BEECHAM OVERSEAS LIMITED Director 2001-03-02 CURRENT 1990-10-29 Active
GLAXO GROUP LIMITED SMITH KLINE & FRENCH LABORATORIES LIMITED Director 2001-03-02 CURRENT 1897-04-21 Active
GLAXO GROUP LIMITED BEECHAM GROUP P L C Director 2001-03-02 CURRENT 1928-01-23 Active
GLAXO GROUP LIMITED SMITHKLINE BEECHAM (H) LIMITED Director 2001-02-28 CURRENT 1996-12-18 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE CAPITAL PLC Director 2001-02-28 CURRENT 1988-05-16 Active
GLAXO GROUP LIMITED SMITHKLINE BEECHAM (INVESTMENTS) LIMITED Director 2001-02-28 CURRENT 1935-06-21 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE FINANCE PLC Director 2001-02-28 CURRENT 1929-10-02 Active
GLAXO GROUP LIMITED ESKAYLAB LIMITED Director 2001-02-19 CURRENT 1908-07-29 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE INTERNATIONAL LIMITED Director 2001-02-19 CURRENT 1988-09-21 Active
GLAXO GROUP LIMITED SMITHKLINE BEECHAM (SWG) LIMITED Director 2001-02-19 CURRENT 1923-05-26 Liquidation
GLAXO GROUP LIMITED SMITHKLINE BEECHAM LEGACY H LIMITED Director 2001-02-19 CURRENT 1925-12-11 Active
GLAXO GROUP LIMITED BEECHAM PRODUCTS LIMITED Director 2001-02-19 CURRENT 1893-04-28 Liquidation
GLAXO GROUP LIMITED SMITHKLINE BEECHAM NOMINEES LIMITED Director 2001-02-16 CURRENT 1952-01-28 Active
GLAXO GROUP LIMITED ALLEN & HANBURYS LIMITED Director 2001-01-31 CURRENT 1893-12-29 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED Director 2001-01-31 CURRENT 1965-01-22 Active
GLAXO GROUP LIMITED GLAXOSMITHKLINE SERVICES UNLIMITED Director 2001-01-31 CURRENT 1972-03-23 Active
GLAXO GROUP LIMITED EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED Director 2001-01-31 CURRENT 1904-02-09 Active
GLAXO GROUP LIMITED WELLCOME LIMITED Director 2001-01-31 CURRENT 1985-11-06 Active
GLAXO GROUP LIMITED GLAXO LABORATORIES LIMITED Director 2001-01-31 CURRENT 1929-05-28 Liquidation
GLAXO GROUP LIMITED GLAXO WELLCOME UK LIMITED Director 2001-01-31 CURRENT 1950-03-25 Active
GLAXO GROUP LIMITED GLAXO WELLCOME HOLDINGS LIMITED Director 2000-12-31 CURRENT 1999-07-07 Dissolved 2017-03-01
GLAXO GROUP LIMITED SMITHKLINE BEECHAM LIMITED Director 2000-12-31 CURRENT 1989-01-24 Active
GLAXO GROUP LIMITED WELLCOME CONSUMER PRODUCTS LIMITED Director 1997-09-29 CURRENT 1993-11-19 Liquidation
GLAXO GROUP LIMITED WELLCOME CONSUMER HEALTHCARE LIMITED Director 1997-09-29 CURRENT 1932-02-29 Active
GLAXO GROUP LIMITED CHARLES MIDGLEY LIMITED Director 1997-09-29 CURRENT 1920-01-13 Liquidation
GLAXO GROUP LIMITED BURROUGHS WELLCOME INTERNATIONAL LIMITED Director 1997-09-29 CURRENT 1955-01-26 Active
GLAXO GROUP LIMITED CLARGES PHARMACEUTICALS LIMITED Director 1992-09-01 CURRENT 1908-12-09 Liquidation

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2023-08-14Voluntary liquidation. Notice of members return of final meeting
2023-03-06Voluntary liquidation Statement of receipts and payments to 2023-01-11
2022-07-29TM01APPOINTMENT TERMINATED, DIRECTOR JOHN MICHAEL SADLER
2022-01-17Resolutions passed:<ul><li>Special resolution for voluntary liquidation to wind up with case start date</ul>
2022-01-17Voluntary liquidation declaration of solvency
2022-01-17Voluntary liquidation declaration of solvency
2022-01-17Appointment of a voluntary liquidator
2022-01-17Appointment of a voluntary liquidator
2022-01-17REGISTERED OFFICE CHANGED ON 17/01/22 FROM 980 Great West Road Brentford Middlesex TW8 9GS
2022-01-17REGISTERED OFFICE CHANGED ON 17/01/22 FROM 980 Great West Road Brentford Middlesex TW8 9GS
2022-01-17AD01REGISTERED OFFICE CHANGED ON 17/01/22 FROM 980 Great West Road Brentford Middlesex TW8 9GS
2022-01-17600Appointment of a voluntary liquidator
2022-01-17LRESSPResolutions passed:
  • Special resolution to wind up on 2022-01-12
2022-01-17LIQ01Voluntary liquidation declaration of solvency
2021-12-30DIRECTOR APPOINTED MR JOHN MICHAEL SADLER
2021-12-30DIRECTOR APPOINTED MS SARAH GHINN
2021-12-30AP01DIRECTOR APPOINTED MR JOHN MICHAEL SADLER
2021-12-24APPOINTMENT TERMINATED, DIRECTOR JEROME CHARLES MAURICE ANDRIES
2021-12-24APPOINTMENT TERMINATED, DIRECTOR EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED
2021-12-24APPOINTMENT TERMINATED, DIRECTOR GLAXO GROUP LIMITED
2021-12-24TM01APPOINTMENT TERMINATED, DIRECTOR JEROME CHARLES MAURICE ANDRIES
2021-12-10Solvency Statement dated 02/12/21
2021-12-10Statement of capital on GBP 1
2021-12-10Statement by Directors
2021-12-10Resolutions passed:<ul><li>Resolution reduction in capital</ul>
2021-12-10SH19Statement of capital on 2021-12-10 GBP 1
2021-12-10SH20Statement by Directors
2021-12-10CAP-SSSolvency Statement dated 02/12/21
2021-12-10RES06Resolutions passed:
  • Resolution of reduction in issued share capital
2021-12-02RP04SH01Second filing of capital allotment of shares GBP14,000,001
2021-11-26SH0123/11/21 STATEMENT OF CAPITAL GBP 14000000
2021-08-10CS01CONFIRMATION STATEMENT MADE ON 10/08/21, WITH NO UPDATES
2021-05-20PARENT_ACCConsolidated accounts of parent company for subsidiary company period ending 31/12/20
2021-05-20AGREEMENT2Notice of agreement to exemption from audit of accounts for period ending 31/12/20
2021-05-20GUARANTEE2Audit exemption statement of guarantee by parent company for period ending 31/12/20
2020-12-09CS01CONFIRMATION STATEMENT MADE ON 09/12/20, WITH UPDATES
2020-09-24CS01CONFIRMATION STATEMENT MADE ON 24/09/20, WITH NO UPDATES
2020-09-22CS01CONFIRMATION STATEMENT MADE ON 11/09/20, WITH NO UPDATES
2020-06-01PARENT_ACCConsolidated accounts of parent company for subsidiary company period ending 31/12/19
2020-03-18TM01APPOINTMENT TERMINATED, DIRECTOR JAMES BORGER
2020-03-17AP01DIRECTOR APPOINTED MR JEROME CHARLES MAURICE ANDRIES
2020-02-20GUARANTEE2Audit exemption statement of guarantee by parent company for period ending 31/12/19
2020-02-20AGREEMENT2Notice of agreement to exemption from audit of accounts for period ending 31/12/19
2019-09-11CS01CONFIRMATION STATEMENT MADE ON 11/09/19, WITH NO UPDATES
2019-06-28AAFULL ACCOUNTS MADE UP TO 31/12/18
2019-04-04TM01APPOINTMENT TERMINATED, DIRECTOR ALAN GEORGE BURNS
2019-03-12AP01DIRECTOR APPOINTED MR CHARALAMPOS PANAGIOTIDIS
2019-02-28AP01DIRECTOR APPOINTED MR JAMES BORGER
2019-02-18TM01APPOINTMENT TERMINATED, DIRECTOR OLEG DUBIANSKIJ
2018-12-03CS01CONFIRMATION STATEMENT MADE ON 03/12/18, WITH NO UPDATES
2018-04-25AAFULL ACCOUNTS MADE UP TO 31/12/17
2018-01-03CS01CONFIRMATION STATEMENT MADE ON 22/12/17, WITH NO UPDATES
2017-07-17AAFULL ACCOUNTS MADE UP TO 31/12/16
2017-02-06AP01DIRECTOR APPOINTED MR OLEG DUBIANSKIJ
2016-12-22LATEST SOC22/12/16 STATEMENT OF CAPITAL;GBP 14000000
2016-12-22CS01CONFIRMATION STATEMENT MADE ON 22/12/16, WITH UPDATES
2016-09-13AAFULL ACCOUNTS MADE UP TO 31/12/15
2015-12-23LATEST SOC23/12/15 STATEMENT OF CAPITAL;GBP 14000000
2015-12-23AR0122/12/15 ANNUAL RETURN FULL LIST
2015-08-19AAFULL ACCOUNTS MADE UP TO 31/12/14
2015-01-07LATEST SOC07/01/15 STATEMENT OF CAPITAL;GBP 14000000
2015-01-07AR0122/12/14 ANNUAL RETURN FULL LIST
2014-08-04AAFULL ACCOUNTS MADE UP TO 31/12/13
2014-01-03LATEST SOC03/01/14 STATEMENT OF CAPITAL;GBP 14000000
2014-01-03AR0122/12/13 ANNUAL RETURN FULL LIST
2014-01-03CH02Director's details changed for Glaxo Group Limited on 2013-03-07
2013-09-18AAFULL ACCOUNTS MADE UP TO 31/12/12
2013-05-30AP04Appointment of corporate company secretary Edinburgh Pharmaceutical Industries Limited
2013-02-18AR0122/12/12 ANNUAL RETURN FULL LIST
2013-02-18AP02CORPORATE DIRECTOR APPOINTED GLAXO GROUP LIMITED
2013-02-18AP02CORPORATE DIRECTOR APPOINTED EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED
2013-02-18TM01APPOINTMENT TERMINATED, DIRECTOR TIMOTHY EDWARDS
2013-02-18TM01APPOINTMENT TERMINATED, DIRECTOR CHARLES COHEN
2013-02-18TM02APPOINTMENT TERMINATION COMPANY SECRETARY RICHARD HALE
2012-12-13AD01REGISTERED OFFICE CHANGED ON 13/12/2012 FROM CHESTERFORD RESEARCH PARK LITTLE CHESTERFORD CAMBRIDGE CB10 1XL
2012-12-06AP01DIRECTOR APPOINTED MR ALAN BURNS
2012-05-24AAFULL ACCOUNTS MADE UP TO 31/12/11
2012-01-05AR0122/12/11 FULL LIST
2011-06-10AAFULL ACCOUNTS MADE UP TO 31/12/10
2011-01-05AR0122/12/10 FULL LIST
2010-07-12AAFULL ACCOUNTS MADE UP TO 31/12/09
2010-07-06MISC123
2010-07-01SH0101/07/10 STATEMENT OF CAPITAL GBP 14000000
2010-05-11MG02DECLARATION OF SATISFACTION IN FULL OR IN PART OF A MORTGAGE OR CHARGE /FULL /CHARGE NO 1
2010-01-05AR0122/12/09 FULL LIST
2010-01-05CH01DIRECTOR'S CHANGE OF PARTICULARS / DR CHARLES COHEN / 04/01/2010
2010-01-04CH01DIRECTOR'S CHANGE OF PARTICULARS / MR TIMOTHY PETER WARREN EDWARDS / 04/01/2010
2009-07-06AAFULL ACCOUNTS MADE UP TO 31/12/08
2009-01-08363aRETURN MADE UP TO 22/12/08; FULL LIST OF MEMBERS
2008-12-2788(2)AD 26/11/08 GBP SI 5000000@1=5000000 GBP IC 200000/5200000
2008-12-02RES04GBP NC 1500000/5500000 25/11/2008
2008-12-02123NC INC ALREADY ADJUSTED 25/11/08
2008-12-02RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2008-07-29288cDIRECTOR'S CHANGE OF PARTICULARS / TIMOTHY EDWARDS / 14/07/2008
2008-07-11MEM/ARTSMEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
2008-07-10CERTNMCOMPANY NAME CHANGED CELLZOME (UK) LIMITED CERTIFICATE ISSUED ON 10/07/08
2008-06-10AAFULL ACCOUNTS MADE UP TO 31/12/07
2008-01-03363aRETURN MADE UP TO 22/12/07; FULL LIST OF MEMBERS
2007-10-04395PARTICULARS OF MORTGAGE/CHARGE
2007-06-07AAFULL ACCOUNTS MADE UP TO 31/12/06
2007-01-09288aNEW SECRETARY APPOINTED
2007-01-09288bSECRETARY RESIGNED
2007-01-09363sRETURN MADE UP TO 22/12/06; FULL LIST OF MEMBERS
2006-07-10AAFULL ACCOUNTS MADE UP TO 31/12/05
2006-01-04363sRETURN MADE UP TO 22/12/05; FULL LIST OF MEMBERS
2005-06-14AAFULL ACCOUNTS MADE UP TO 31/12/04
2005-02-04363(287)REGISTERED OFFICE CHANGED ON 04/02/05
2005-02-04363sRETURN MADE UP TO 22/12/04; FULL LIST OF MEMBERS
2004-09-23288aNEW DIRECTOR APPOINTED
2004-09-20288bDIRECTOR RESIGNED
2004-06-22288aNEW DIRECTOR APPOINTED
2004-06-22288aNEW DIRECTOR APPOINTED
2004-06-22288bDIRECTOR RESIGNED
2004-06-22288bSECRETARY RESIGNED
2004-06-22288aNEW SECRETARY APPOINTED
2004-06-2288(2)RAD 22/12/03--------- £ SI 199999@1=199999 £ IC 1/200000
2003-12-22NEWINCINCORPORATION DOCUMENTS CERTIFICATE OF INCORPORATION STATEMENT OF DIRECTORS & REGISTERED OFFICE DECLARATION OF COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72190 - Other research and experimental development on natural sciences and engineering




Licences & Regulatory approval
We could not find any licences issued to CELLZOME LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Share
Risks
Legal Notices
Appointmen2022-01-17
Fines / Sanctions
No fines or sanctions have been issued against CELLZOME LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 1
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 1
Details of Mortgagee Charges
Charge Type Date of Charge Charge Status Mortgagee
DEBENTURE 2007-09-27 Satisfied GE CORPORATE FINANCE BANK SAS
Filed Financial Reports
Annual Accounts
2014-12-31
Annual Accounts
2013-12-31
Annual Accounts
2012-12-31
Annual Accounts
2011-12-31
Annual Accounts
2010-12-31
Annual Accounts
2009-12-31

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on CELLZOME LIMITED

Intangible Assets
Patents
We have not found any records of CELLZOME LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for CELLZOME LIMITED
Trademarks
We have not found any records of CELLZOME LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for CELLZOME LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72190 - Other research and experimental development on natural sciences and engineering) as CELLZOME LIMITED are:

OAKLEA LTD. £ 237,880
TRL LIMITED £ 130,521
SGS MIS ENVIRONMENTAL LTD £ 18,077
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 13,354
WILDKNOWLEDGE LTD £ 8,604
FONTENERGY LTD £ 4,300
T-CUBED LTD £ 2,599
MARWELL WILDLIFE £ 1,089
CAMPDEN BRI (CHIPPING CAMPDEN) LIMITED £ 1,000
SITE ANALYTICAL SERVICES LIMITED £ 950
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
Outgoings
Business Rates/Property Tax
No properties were found where CELLZOME LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by CELLZOME LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2012-03-0129420000Separate chemically defined organic compounds, n.e.s.
2012-02-0129420000Separate chemically defined organic compounds, n.e.s.
2012-02-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-01-0139269097Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s.
2011-12-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-11-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-11-0139269097Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s.
2011-10-0129036990
2011-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-09-0129122900Cyclic aldehydes, without other oxygen function (excl. benzaldehyde)
2011-09-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2011-09-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-08-0128352400Phosphates of potassium
2011-08-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-07-0128352400Phosphates of potassium
2011-07-0129310099
2011-07-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-07-0139269097Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s.
2011-06-0129215990Aromatic polyamines and their derivatives; salts thereof (excl. o-phenylenediamine, m-phenylenediamine, p-phenylenediamine or diaminotoluenes and their derivatives, and salts thereof, m-phenylenebis"methylamine", 2,2'-dichloro-4,4'-methylenedianiline, 4,4'-bi-o-toluidine and 1,8-naphthylenediamine)
2011-06-0129420000Separate chemically defined organic compounds, n.e.s.
2011-06-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-05-0129
2011-05-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-04-0129339190Alprazolam "INN", camazepam "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl loflazepate "INN", fludiazepam "INN", flunitrazepam "INN", flurazepam "INN", halazepam "INN", lorazepam "INN", lormetazepam "INN", mazindol "INN", medazepam "INN", midazolam "INN", nimetazepam "INN", nitrazepam "INN", nordazepam "INN", oxazepam "INN", pinazepam "INN", prazepam "INN", pyrovalerone "INN", temazepam "INN", tetrazepam "INN" and triazolam "INN", salts thereof, a
2011-04-0129420000Separate chemically defined organic compounds, n.e.s.
2011-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-03-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2011-03-0129420000Separate chemically defined organic compounds, n.e.s.
2011-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-02-0129342020Di"benzothiazol-2-yl"disulphide; benzothiazol-2-thiol "mercaptobenzothiazole" and its salts
2011-02-0129420000Separate chemically defined organic compounds, n.e.s.
2011-02-0130041000Medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale
2011-02-0130049000Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2011-02-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-02-0139172290Rigid tubes, pipes and hoses, of polymers of propylene (excl. seamless and cut to length only)
2011-02-0190278099Non-electronic instruments and apparatus for physical or chemical analysis or for determining surface tension or the like, or for measuring heat or sound, n.e.s.
2011-01-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2011-01-0129374000
2011-01-0129420000Separate chemically defined organic compounds, n.e.s.
2011-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-01-0139269097Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s.
2010-12-0129333999Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
2010-12-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2010-12-0129362100Vitamins A and their derivatives, used primarily as vitamins
2010-12-0129420000Separate chemically defined organic compounds, n.e.s.
2010-12-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-11-0129420000Separate chemically defined organic compounds, n.e.s.
2010-11-0138200000Anti-freezing preparations and prepared de-icing fluids (excl. prepared additives for mineral oils or other liquids used for the same purposes as mineral oils)
2010-11-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-11-0138249097Chemical products and preparations of the chemical or allied industries, incl. those consisting of mixtures of natural products, n.e.s.
2010-10-0128045090Tellurium
2010-10-0128151100Sodium hydroxide "caustic soda" solid
2010-10-0129036990
2010-10-0129374000
2010-10-0129420000Separate chemically defined organic compounds, n.e.s.
2010-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-09-0129420000Separate chemically defined organic compounds, n.e.s.
2010-09-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-08-0128100090Oxides of boron and boric acids (excl. diboron trioxide)
2010-08-0129
2010-08-0129310099
2010-08-0129335995Heterocyclic compounds with nitrogen hetero-atom"s" only, containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure (excl. malonylurea "barbituric acid" and its derivatives, allobarbital "INN", amobarbital "INN", barbital "INN", butalbital "INN", butobarbital "INN", cyclobarbital "INN", methylphenobarbital "INN", pentobarbital "INN", phenobarbital "INN", secbutabarbital "INN", secobarbital "INN", vinylbital "INN", loprazolam "INN", mecloqualone "INN", methaqu
2010-08-0129420000Separate chemically defined organic compounds, n.e.s.
2010-08-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-07-0129331990Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyrazole ring, whether or not hydrogenated, in the structure (excl. phenazone "antipyrin" and its derivatives and phenylbutazone "INN")
2010-07-0129341000Heterocyclic compounds containing an unfused thiazole ring, whether or not hydrogenated, in the structure
2010-07-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2010-07-0129420000Separate chemically defined organic compounds, n.e.s.
2010-07-0130049000Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2010-07-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-07-0139269097Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s.
2010-06-0129310010
2010-06-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2010-06-0129420000Separate chemically defined organic compounds, n.e.s.
2010-06-0130069200Waste pharmaceuticals
2010-06-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-05-0129341000Heterocyclic compounds containing an unfused thiazole ring, whether or not hydrogenated, in the structure
2010-05-0129420000Separate chemically defined organic compounds, n.e.s.
2010-05-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-04-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2010-04-0129374000
2010-04-0129420000Separate chemically defined organic compounds, n.e.s.
2010-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-03-0129159000
2010-03-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2010-03-0130029030Animal blood prepared for therapeutic, prophylactic or diagnostic uses
2010-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-02-0129
2010-02-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-01-0128499010Carbides of boron, whether or not chemically defined
2010-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded CELLZOME LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded CELLZOME LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.
    Other companies at postcode L2 5RH